Ke K - Search Results

1

A meta-analysis comparing hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma.

Yan L, Lin J, Ke K, Wu Z, Huang J, Huang N, Yang W. Yan L, et al. Among authors: ke k. Transl Cancer Res. 2022 Jan;11(1):99-112. doi: 10.21037/tcr-21-1839. Transl Cancer Res. 2022. PMID: 35261888 Free PMC article.

2

Is Multilayer Bare Stent Safe or Effective for the Treatment of Aortic Aneurysms? A Meta-analysis with Early and Mid-term Outcomes.

Ke K, Zheng H, Yang W. Ke K, et al. Ann Vasc Surg. 2017 Apr;40:112-119. doi: 10.1016/j.avsg.2016.06.030. Epub 2016 Sep 23. Ann Vasc Surg. 2017. PMID: 27671451 Review.

3

FGG promotes migration and invasion in hepatocellular carcinoma cells through activating epithelial to mesenchymal transition.

Zhang X, Wang F, Huang Y, Ke K, Zhao B, Chen L, Liao N, Wang L, Li Q, Liu X, Wang Y, Liu J. Zhang X, et al. Among authors: ke k. Cancer Manag Res. 2019 Feb 19;11:1653-1665. doi: 10.2147/CMAR.S188248. eCollection 2019. Cancer Manag Res. 2019. PMID: 30863175 Free PMC article.

4

Endovascular Repair of Spontaneous Iliac Vein Rupture.

Zheng H, Yang WZ, Ke K, Huang JY. Zheng H, et al. Among authors: ke k. Ann Vasc Surg. 2021 May;73:510.e25-510.e28. doi: 10.1016/j.avsg.2020.11.040. Epub 2020 Dec 26. Ann Vasc Surg. 2021. PMID: 33373771

5

Constitutive TDO2 expression promotes liver cancer progression by an autocrine IL-6 signaling pathway.

Wu Z, Yan L, Lin J, Ke K, Yang W. Wu Z, et al. Among authors: ke k. Cancer Cell Int. 2021 Oct 17;21(1):538. doi: 10.1186/s12935-021-02228-9. Cancer Cell Int. 2021. PMID: 34657635 Free PMC article.

6

Efficacy and safety of hepatic artery infusion chemotherapy combined with tyrosine kinase inhibitors plus programmed death-1 inhibitors for hepatocellular carcinoma refractory to transarterial chemoembolization.

Lin LW, Ke K, Yan LY, Chen R, Huang JY. Lin LW, et al. Among authors: ke k. Front Oncol. 2023 May 3;13:1178428. doi: 10.3389/fonc.2023.1178428. eCollection 2023. Front Oncol. 2023. PMID: 37207144 Free PMC article.

7

Increased Expression of CD74 in Atherosclerosis Associated with Inflammatory Responses of Endothelial Cells and Macrophages.

Ke K, Wu Z, Lin J, Lin L, Huang N, Yang W. Ke K, et al. Biochem Genet. 2024 Feb;62(1):294-310. doi: 10.1007/s10528-023-10421-w. Epub 2023 Jun 19. Biochem Genet. 2024. PMID: 37335371

8

Efficacy and safety of transarterial chemoembolization combined with lenvatinib, programmed death-1 inhibitor, and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombosis.

Lin LW, Yan LY, Ke K, Yang WZ, Lin JQ, Huang N. Lin LW, et al. Among authors: ke k. Brachytherapy. 2023 Nov-Dec;22(6):858-871. doi: 10.1016/j.brachy.2023.06.229. Epub 2023 Aug 12. Brachytherapy. 2023. PMID: 37574351

9

Transthyretin promotes the invasion of combined hepatocellular cholangiocarcinoma by tumor-associated macrophages.

Ke K, Lin J, Huang N, Yan L, Liao R, Yang W. Ke K, et al. Cancer Rep (Hoboken). 2023 Oct;6(10):e1888. doi: 10.1002/cnr2.1888. Epub 2023 Sep 9. Cancer Rep (Hoboken). 2023. PMID: 37688511 Free PMC article.

10

Safety and efficacy of biliary stenting combined with iodine-125 seed strand followed by hepatic artery infusion chemotherapy plus lenvatinib with PD-1 inhibitor for the treatment of extrahepatic cholangiocarcinoma with malignant obstructive jaundice.

Lin LW, Ke K, Chen R, Yang WZ, Huang N, Wu ZZ. Lin LW, et al. Among authors: ke k. Front Immunol. 2024 Jan 15;14:1286771. doi: 10.3389/fimmu.2023.1286771. eCollection 2023. Front Immunol. 2024. PMID: 38288113 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

332 results

Search Page

Filters